The group was established only two years ago and has nine hospitals.
It is understood that Guo Zhong Jian Kang Group Co., Ltd. was established on June 6, 20 18, and is a wholly-owned subsidiary invested by State Grid Corporation.
With a registered capital of 3 billion yuan, the Group has 9 medical institutions, including 2 tertiary general hospitals, 3 specialized hospitals 1 family, and 5 second-class first-class hospitals, referring to the occupational disease prevention hospital 1 family managed by second-class first-class hospitals.
At the beginning of its establishment, Jian Kang, a junior high school and a senior high school, focused on the health care industry, taking health as the main line, medical care as the foundation and pension as the core, and built a brand-new intelligent and healthy pension platform by building the whole industrial chain of health care, health management, medical security, health tourism and "internet plus".
At the unveiling ceremony of that year, Zhang Gang, the chairman of Jian Kang, said that Jian Kang, a junior high school, would use social resources for professional management and operation, and strive to develop into a professional health care industry group with 10000 beds within/kloc-0.
At that time, the relevant person in charge of Jian Kang in junior high school planned to sell 25% of the shares, and the shareholding ratio of State Grid will be reduced to 25% in the future, and the actual controller will become SASAC. The other 50% shares have been discussed by two interested partners.
Now, 50% of Jian Kang's shares in junior high school have been decided to be spent on China General Technology Group. If the shareholding ratio of State Grid is reduced to 25% in the future, it will continue to sell shares in the future.
The recipient operates more than 20,000 beds.
It is understood that China General Technology Group is one of the three central enterprises with medicine as their main business approved by the State-owned Assets Supervision and Administration Commission of the State Council, and one of the six central enterprises allowed to participate in the resource integration of medical institutions run by state-owned enterprises. Its business scope covers the pharmaceutical industry and other fields, forming a relatively complete industrial chain.
Medicine, medical treatment and health are one of the three core businesses of China General Technology Group. In 20 17, the national ranking of pharmaceutical industry was 5 1, and the national ranking of pharmaceutical business was 7.
According to reports, the group * * * has four listed companies, including two in the medical field, namely China Pharmaceutical (600056. SH) and Global Medical (02666). HK)。
Official website Group shows that its medical service business actively undertakes medical institutions spun off by state-owned enterprises and central enterprises. At present, 87 integrated medical institutions have been undertaken, with 210.3 million beds; The Group can also provide comprehensive medical services integrating financing, equipment, technology and training for hospital customers. With more than 65,438+0,000 hospital customers and more than 60 international top medical institution partners, it has become a leading large-scale comprehensive medical service provider in China.
When accepting the management right of junior high school Jian Kang, Xu Xianping, chairman of China General Technology Group, said that junior high school Jian Kang has a good medical foundation and a large customer base. By adhering to the principle of marketization, we will participate in the equity diversification of junior high school Jian Kang in accordance with the market-oriented mechanism, promote cooperation between the two sides, and build a first-class competitive health care industry group.
Further expand the business of hospital group
According to the medical management report, in 20 19, Global Medical signed project cooperation contracts with Angang Group, Pangang Group, China Electronics, China Railway State-owned Assets and Yangmei Group in the form of joint venture and delisting in the open market, and continued to actively participate in the integration and undertaking of hospitals run by state-owned enterprises, and comprehensively improved the technical level of hospitals around discipline construction, operation management, information upgrading, supply chain management and hospital reconstruction and expansion.
20 19 is a crucial year for global medical to build a medical and health industry group and promote the implementation of strategic upgrading. The scale of hospital groups continued to expand, the medical financial business developed steadily, and the foundation of collectivization was initially formed. In 20 19, the company realized a year-on-year increase of 58.6% to 6815.6 million yuan, a year-on-year increase of 2 1.0% to1634.4 million yuan, and a year-on-year increase of10.65438.
By the end of 20 19, 12, and 3 1, the company has signed more than 40 medical institutions (including 5 tertiary hospitals and more than 20 secondary hospitals), and the number of hospital beds exceeds 15000. In the same year, 24 medical institutions were integrated (including 3 Grade-A hospitals and 6,543.8+02 Grade-II hospitals), and the operating performance of the hospital group achieved a breakthrough expansion, with an income of 2,046.9 million yuan, an increase of 6,543.8+0.965 billion yuan. This year, the profit was 654.38+0.075 million yuan, an increase of 654.38+0.65, 4.38+0.53 million yuan over the same period of last year.
The company actively extends the healthy industrial chain around the hospital group. In terms of medical technology, we introduced world-leading medical equipment products to effectively improve the medical technology level of hospital customers. In terms of medical information business, based on member hospitals, with the three main lines of Internet health service, smart hospital overall solution, medical big data and artificial intelligence service as the core, we constantly improve the Internet health platform and strive to create an "online+offline" service model. In the aspect of supply chain management, the construction and deployment of medical supply chain system and sunshine procurement management platform for medical materials are carried out around hospital business; Sort out the current situation of the use of drugs and medical consumables in hospitals, constantly improve business processes, and standardize the centralized procurement of regional drug supply chains.
The reorganization of state-owned hospitals is still in progress.
Statistics show that there are more than 7,000 enterprise hospitals in China, accounting for nearly two-thirds of the public hospital system. In the 1980s, state-owned enterprises such as coal mines and steel companies generally operated well, and the treatment and welfare of enterprise hospitals were superior to those of government-sponsored public hospitals, making them the first choice for many medical college graduates. Now, this once attractive "sweet cake" is gradually withdrawing from the historical stage.
On March 20 16, the State Council's Notice on Printing and Distributing the Work Plan for Accelerating the Stripping of Social Functions of State-owned Enterprises to Solve the Problems Left over from History (Guo Fa [20 16] 19) clearly defined the objectives and tasks of deepening the reform of medical institutions run by state-owned enterprises, and required that the deepening reform of medical institutions run by state-owned enterprises should be basically completed by the end of 2065 438+06.
In 20 17, six ministries and commissions issued the Guiding Opinions on Deepening the Reform of Education and Medical Institutions Run by State-owned Enterprises, demanding that the restructuring, handover and centralized management of medical institutions run by State-owned enterprises be basically completed by the end of 2065 438+07, and defining four paths for deepening the reform of medical institutions: handover to local authorities, closure and revocation, and resource integration and reorganization.
From 2065438 to July 2008, the State-owned Assets Supervision and Administration Commission designated six central enterprises, namely China Resources Health, Sinopharm Group, China Chengtong, China General Motors, China SDIC and China Guo Xin, as the trusteeship platforms, and classified the state-owned hospitals that have not completed the restructuring into the trusteeship platforms.
However, the restructuring of enterprise hospitals, which was originally scheduled to be completed by the end of 20 18, was delayed from the original end of 20 18 to 202 1 at the national level due to the difficult stripping process, slow progress and great difficulty in reform.
According to the Health News, at the annual meeting of the National Corporate Hospital Conference and Corporate Hospital Branch held at the end of 20 19, Jin Yongcheng, chairman of the Corporate Hospital Branch of China Hospital Association, introduced that the divestiture of state-owned hospitals was mainly carried out in several ways:
First, transfer to local governments and universities;
The second is to integrate resources through asset transfer, free transfer and custody;
The third is restructuring.
The advantage of industrialization and marketization of medical groups lies in that the sideline of enterprise hospitals has become the main business, and the capital investment and channels have been solved. However, it still faces the survival and development problems such as the lack of compensation mechanism.
Jin Yongcheng said that by the end of 20 18, 90% of enterprise hospitals had completed the divestiture task. However, due to the large investment scale, long payback period and difficult realization of medical institutions, the enthusiasm of all walks of life for capital investment has obviously cooled down, and the reform and restructuring of enterprise hospitals may last for a long time.